Drugs / SYNB1353
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05462132 | Jul → Nov 2022 | homocystinuria | Synlogic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SYNB1353 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05462132 ↗ |
| Modality | Cell therapy | “3 × 10\^11 live cells of SYNB1353” NCT05462132 ↗ |
| Route | Oral | “intended for oral administration” NCT05462132 ↗ |